
Health Catalyst (NASDAQ:HCAT) brought in sales totaling $64.72 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 22.44%, resulting in a loss of $48.99 million. In Q3, Health Catalyst brought in $61.74 million in sales but lost $40.01 million in earnings.